Please assess the completion status of the following clinical trial:

Trial Title: Biological Effects of Dehydroepiandrosterone (DHEA) in the Elderly

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Healthy women and men~* Age 60 or older~* Age-appropriate DHEAS levels, but 70% lower than normal DHEAS levels for a 25-year old~Exclusion Criteria:~* Contraindications to DHEA treatment (personal history of breast cancer or other estrogen-dependent neoplasms, acute liver disease, undiagnosed vaginal bleeding in women, history or evidence of prostate cancer or benign prostatic hyperplasia (BPH) in men)~* Angina~* Resting blood pressure over 180/95~* Chronic infections~* Hypothyroidism~* Depression~* Hormone therapy within the previous 6 months~* Insulin-dependent or poorly controlled diabetes~* Serum DHEAS level greater than 140 micrograms per deciliter (µg/dL)~Prohibited Medications:~* Hormone therapy other than stable regimen of thyroid replacement~* Oral glucocorticoids~* Insulin

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).